Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice

Author： Frueh Felix W  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.5, 2010-05, pp. : 657-660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

What is next in pharmacogenomics? Translating it to clinical practice

By Valdes Jr Roland   Linder Mark W   Jortani Saeed A  

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 499-505

Future Medicine

Access to resources Recommend Favorite

Translating Comparative Effectiveness Research into Clinical Practice: The UK Experience

By Walley Tom  

Drugs, Vol. 72, Iss. 2, 2012-01 ,pp. : 163-170

Adis International

Access to resources Recommend Favorite

Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice

By Squassina Alessio   Manchia Mirko   Manolopoulos Vangelis G   Artac Mehmet   Lappa-Manakou Christina   Karkabouna Sophia   Mitropoulos Konstantinos   Zompo Maria Del   Patrinos George P  

Pharmacogenomics, Vol. 11, Iss. 8, 2010-08 ,pp. : 1149-1167

Future Medicine

Access to resources Recommend Favorite

Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe

By van den Akker-van Marle M Elske   Gurwitz David   Detmar Symone B   Enzing Christine M   Hopkins Michael M   Gutierrez de Mesa Emma   Ibarreta Dolores  

Pharmacogenomics, Vol. 7, Iss. 5, 2006-07 ,pp. : 783-792

Future Medicine

Access to resources Recommend Favorite

Translating alteplase use in stroke to clinical practice

By  

Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite